Major Depressive Disorder Clinical Trials in Stanford, California

4 studies are recruiting for major depressive disorder in Stanford, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    The study will evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in participants with MDD on improving symptoms of depression.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Neurocrine Clinical Site, Stanford, California
    Locations
    35 in total
    Run by
    Neurocrine Biosciences

    See if you can join NCT06963021 on ClinicalTrials.gov

  2. Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans

    Transcranial magnetic stimulation (TMS) is an effective treatment for depression, but clinical outcome is suboptimal, partially because investigators are missing biologically-grounded brain markers which show that TMS is modifying activity at the intended target in the brain. The goal of this propo…

    Stage
    Not phased
    Ages
    18 to 65
    Site
    Stanford University, Stanford, California
    Run by
    Stanford University

    See if you can join NCT05996900 on ClinicalTrials.gov

  3. Biomarker-guided rTMS for Treatment Resistant Depression

    Repetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. The investigators are continuing to learn how to optimize outcomes from rTMS treatment. The purpose of this research project is to use brain network connectivity patterns as measured by resting state functional magne…

    Stage
    Phase 3
    Ages
    22 to 65
    Site
    Stanford University, Stanford, California
    Locations
    2 in total
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT04041479 on ClinicalTrials.gov

  4. Optimizing Brain Excitability in Depression

    The goal of this study is to improve depression treatment by establishing reliable prefrontal excitability markers through Targeting with Automated Real-time Guidance for Enhancing TEPs (TARGET).

    Stage
    Not phased
    Ages
    18 to 65
    Site
    Stanford University, Stanford, California
    Locations
    2 in total
    Run by
    Stanford University

    See if you can join NCT07242105 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.